Shahram Attarian

Also affiliated with Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Laboratoire National de Référence, Institut de Neurosciences de la Timone, ERN GUARD-Heart, Hôpital de la Timone, French Clinical Research Infrastructure Network

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial”.

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

The Lancet Neurology(2021)10.1016/s1474-4422(21)00241-6

N/A

2.9DataRank · unranked

185 citations

Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub +95 more

Predicting Outcome in Guillain-Barré Syndrome

Neurology(2021)10.1212/wnl.0000000000013139

N/A

2.5DataRank · unranked

68 citations

Hester F. Lingsma, Christa Walgaard, Badrul Islam, Nowshin Papri, Amy Davidson +95 more

104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)

Journal of Neurology(2024)10.1007/s00415-024-12236-0

N/A

0.803DataRank · unranked

28 citations

Priya S. Kishnani, Drago Bratkovic, Barry J. Byrne, Kristl G. Claeys, Jordi Díaz‐Manera +79 more

Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2024)10.1016/s1474-4422(24)00373-9

N/A

0.653DataRank · unranked

31 citations

Andreas Leha, Helen Bidner, Isabell Cordts, Johannes Dorst, René Günther +28 more

Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa

Journal of Neuromuscular Diseases(2023)10.3233/jnd-230175

N/A

0DataRank · unranked

3 citations

Emmanuelle Salort Campana, Shahram Attarian, Jordi Díaz‐Manera, Mazen M. Dimachkie, Magali Periquet +5 more

Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study

European Journal of Neurology(2024)10.1111/ene.16335

N/A

0DataRank · unranked

11 citations

Judith Drenthen, Laura de Koning, Peter Van den Bergh, Robert D. M. Hadden, Satoshi Kuwabara +34 more